By otakuyassine3@gmail.com 
Integer Holdings Co. (NYSE:ITGR – Get Free Report) has been assigned an average rating of “Moderate Buy” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $145.44.
A number of equities research analysts have issued reports on the stock. KeyCorp upped their price target on shares of Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a report on Tuesday, October 15th. Benchmark raised their target price on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, October 21st. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Citigroup increased their price objective on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $140.00 target price (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th.
Get Our Latest Research Report on Integer
Institutional Investors Weigh In On Integer
Several institutional investors and hedge funds have recently bought and sold shares of ITGR. Lord Abbett & CO. LLC grew its stake in shares of Integer by 3.5% in the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock valued at $37,716,000 after purchasing an additional 9,754 shares during the period. TD Private Client Wealth LLC grew its position in Integer by 15.5% in the third quarter. TD Private Client Wealth LLC now owns 1,420 shares of the medical equipment provider’s stock valued at $185,000 after acquiring an additional 191 shares during the period. Geode Capital Management LLC raised its stake in Integer by 1.2% during the third quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock worth $99,408,000 after acquiring an additional 9,421 shares in the last quarter. Public Employees Retirement System of Ohio lifted its holdings in shares of Integer by 3,443.4% during the third quarter. Public Employees Retirement System of Ohio now owns 13,890 shares of the medical equipment provider’s stock valued at $1,806,000 after acquiring an additional 13,498 shares during the period. Finally, XTX Topco Ltd boosted its stake in shares of Integer by 31.5% in the 3rd quarter. XTX Topco Ltd now owns 6,764 shares of the medical equipment provider’s stock valued at $879,000 after purchasing an additional 1,620 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.
Integer Stock Down 0.3 %
Shares of ITGR stock opened at $132.17 on Friday. The stock’s 50 day simple moving average is $135.18 and its 200 day simple moving average is $127.12. Integer has a twelve month low of $94.56 and a twelve month high of $142.76. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The company has a market capitalization of $4.43 billion, a price-to-earnings ratio of 40.79, a PEG ratio of 2.02 and a beta of 1.12.
Integer (NYSE:ITGR – Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The business had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. During the same period in the previous year, the company earned $1.27 earnings per share. Integer’s revenue for the quarter was up 8.7% on a year-over-year basis. As a group, research analysts predict that Integer will post 5.33 EPS for the current year.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Further Reading
Receive News & Ratings for Integer Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Integer and related companies with MarketBeat.com’s FREE daily email newsletter.